Bank of Nova Scotia Trust’s Amgen AMGN Stock Holding History

Bank of Nova Scotia Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-351	Closed	-$66K	–	138
2017 Q3	$66K	Buy	+351	New	+$62.2K	0.01%	221

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Nova Scotia Trust's AMGN Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Amgen (AMGN) in Q4 2017, closing a stake of 351 shares — an estimated $66K sold.

Bank of Nova Scotia Trust first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $66K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Bank of Nova Scotia Trust reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Bank of Nova Scotia Trust sold 351 Amgen shares in Q4 2017, an estimated $66K.
Bank of Nova Scotia Trust first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
Bank of Nova Scotia Trust's Amgen position peaked at $66K in Q3 2017.
1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.